Space & Satellites
Airbus Delivers European Service Module for Artemis IV Lunar Mission
Airbus ships the fourth European Service Module to NASA for Artemis IV, supporting Orion and the Lunar Gateway in advancing lunar exploration.
Artemis IV Gets Its Wings: Airbus Ships Key Module for Lunar Gateway Mission
In a significant step forward for humanity’s return to the Moon, Airbus has completed and shipped the fourth European Service Module (ESM-4) from its facilities in Bremen, Germany. This critical piece of hardware is now en route to NASA’s Kennedy Space Center in Florida, where it will be integrated into the Orion spacecraft destined for the Artemis IV mission. The event marks a tangible milestone in the ongoing international collaboration to establish a long-term human presence on and around the Moon, setting the stage for more complex deep-space exploration.
The Artemis program, led by NASA, is not just about planting flags and leaving footprints. It represents a concerted global effort to build a sustainable lunar presence, which includes the construction of the Gateway, a small space station orbiting the Moon. This ambitious undertaking relies on contributions from international partners like the European Space Agency (ESA), which tasked Airbus with developing and building the powerhouse for the Orion spacecraft. The successful delivery of ESM-4 underscores Europe’s vital role in this new era of space exploration, which aims to use the Moon as a proving ground for future missions to Mars.
At its core, the Orion spacecraft is composed of two main parts: the crew module, where astronauts will live and work, and the service module, which provides the essential propulsion and life support. The European Service Module is the backbone of the spacecraft, supplying everything needed to keep the crew alive and the mission on course. Its timely shipment is a testament to the engineering prowess and collaborative spirit driving the Artemis missions forward.
The Powerhouse Behind Orion
A Technological Marvel for Deep Space
The European Service Module is far more than just a fuel tank; it is a complex and sophisticated system responsible for the Orion spacecraft’s primary functions once it leaves Earth’s orbit. The ESM handles propulsion, power generation, thermal control, and life support. It is equipped with 33 engines, including a main engine repurposed from the Space Shuttle program, which provides the powerful thrust needed for major orbital maneuvers. A host of smaller thrusters allows for precise attitude control and positioning in the vacuum of space.
Powering a mission to the Moon and beyond requires a substantial amount of energy. The ESM addresses this with four large solar arrays that span 19 meters when fully deployed, generating over 11 kilowatts of electricity, enough to power several households. This energy is crucial for running all of Orion’s onboard systems. Furthermore, the module manages the spacecraft’s thermal environment, protecting it from the extreme temperature swings of deep space, and carries the essential consumables for the crew, including tanks for water, oxygen, and nitrogen.
This advanced technology doesn’t come from a vacuum. The ESM’s design is based on ESA’s highly successful Automated Transfer Vehicle (ATV), which completed multiple missions to resupply the International Space Station. This heritage provides a foundation of proven reliability, adapted and upgraded for the unique challenges of crewed missions to the Moon. The development, led by prime contractor Airbus on behalf of ESA, involves a network of specialized companies across Europe, including Thales Alenia Space, which supplies key structural and thermal components.
The Journey to the Launchpad
The journey for ESM-4 began long before its transatlantic voyage. Its construction at the Airbus facility in Bremen, Germany, represents thousands of hours of precision engineering and assembly. Now complete, the module is carefully packed and transported to NASA’s Kennedy Space Center, where it will enter the next phase of its pre-flight preparations.
Upon arrival in Florida, the work is far from over. The ESM-4 will undergo a series of rigorous tests to verify its systems are ready for the harsh environment of space. Once these checks are complete, it will be carefully integrated with the Orion Crew Module. This delicate process connects all the power, data, and life support lines between the two sections, effectively creating the complete Orion spacecraft that will carry astronauts on the Artemis IV mission.
This intricate dance of manufacturing, transportation, and integration highlights the deeply collaborative nature of the Artemis program. While Airbus is the prime contractor for the ESM, its creation involves a wide industrial network across Europe, all working under the direction of ESA. This pan-European effort culminates in a single piece of hardware that is then handed over to NASA, symbolizing the trust and shared vision of the international partnership.
“Delivering the fourth ESM takes us one step closer to a new space era with a lunar space station and increased opportunities for deep space scientific research. Europe’s role, through ESA, is crucial in this pioneering NASA-led programme.” – Ralf Zimmermann, Head of Space Exploration at Airbus.
Paving the Way for the Lunar Gateway
A Mission of Firsts
The Artemis IV mission, slated for late 2028, is poised to be a landmark flight in the program. While Artemis III aims to return humans to the lunar surface, Artemis IV will be the first mission to dock with the Gateway, the orbiting lunar outpost. This maneuver is a critical step in building out the infrastructure needed for a permanent human presence around the Moon.
A primary objective for Artemis IV is the delivery of the International Habitation Module (I-Hab) to the Gateway. This European-built module will expand the living and working space for astronauts aboard the station, significantly enhancing its capabilities for long-duration stays and scientific research. The ability of the Orion spacecraft, powered by the ESM-4, to transport and dock such a large module is a key demonstration of the program’s architectural plan.
The mission fits into a carefully planned sequence of flights that progressively build on each other’s successes. Following the uncrewed Artemis I test flight in 2022 and the upcoming crewed lunar flyby of Artemis II, the program will move toward increasingly complex objectives. Artemis IV represents a shift from short-term sorties to the establishment of a permanent foothold in lunar orbit, a crucial pivot toward making humanity a multi-planetary species.
The Gateway: Humanity’s Outpost in Lunar Orbit
The Gateway is arguably one of the most ambitious elements of the Artemis program. It is an international collaboration to build humanity’s first space station around the Moon, serving as a multi-purpose outpost for exploration and science. Unlike the International Space Station in low Earth orbit, the Gateway will occupy a unique orbit that provides access to the entire lunar surface and a strategic staging point for missions farther afield.
This lunar station will function as a command center, a science lab, and a temporary home for astronauts. It will allow for the aggregation of landers and other hardware, enabling more complex and sustainable missions to the lunar surface. Moreover, the Gateway will be a crucial platform for conducting research in a deep-space environment, helping scientists understand the challenges of long-duration spaceflight and test technologies needed for future human missions to Mars.
The construction and operation of the Gateway are a global effort, with NASA, ESA, the Canadian Space Agency (CSA), and the Japan Aerospace Exploration Agency (JAXA) all contributing key components. The first elements, the Power and Propulsion Element (PPE) and the Habitation and Logistics Outpost (HALO), are already well into production. The arrival of the I-Hab on Artemis IV will mark a major milestone in the station’s assembly, transforming it into a truly capable outpost for humanity on the frontier of space.
Conclusion: Building a Future in Deep Space
The shipment of the fourth European Service Module is more than a logistical update; it is a clear and tangible sign of progress in the Artemis program. It represents the successful collaboration between international partners and the steady cadence of hardware deliveries required to turn ambitious plans into reality. The critical role of the ESM, built by Airbus for ESA, highlights Europe’s position as an indispensable partner in NASA’s vision for lunar exploration.
Each milestone, from the completion of a service module to the launch of a new mission, builds the foundation for a sustainable human presence beyond Earth. The work being done today on Artemis IV and the Gateway is not just about reaching the Moon. It is about creating a permanent infrastructure that will enable decades of scientific discovery and prepare humanity for its next great leap: sending astronauts to Mars.
FAQ
Question: What is the European Service Module (ESM)?
Answer: The ESM is the powerhouse of NASA’s Orion spacecraft, providing propulsion, electrical power, thermal control, and life support (water, oxygen, and nitrogen) to the crew module. It is Europe’s primary contribution to the Artemis program, developed by Airbus for the European Space Agency (ESA).
Question: What is special about the Artemis IV mission?
Answer: Artemis IV will be the first mission to dock with the Gateway, a new space station in lunar orbit. A key objective of the mission is to deliver the International Habitation Module (I-Hab), a critical component that will expand the station’s living and working quarters.
Question: What is the Gateway?
Answer: The Gateway is an international project to build a small space station in orbit around the Moon. It will serve as a multi-purpose outpost for astronauts, a staging point for missions to the lunar surface, a science laboratory, and a testbed for technologies needed for future missions to Mars.
Sources: Airbus Press Release
Photo Credit: Airbus
Space & Satellites
Varda and United Therapeutics Partner for Orbital Drug Manufacturing
Varda Space Industries and United Therapeutics collaborate to develop microgravity-enabled treatments for rare pulmonary diseases using orbital pharmaceutical manufacturing.
On May 13, 2026, Varda Space Industries and United Therapeutics Corporation announced a landmark collaboration to manufacture pharmaceuticals in low Earth orbit (LEO). The partnership focuses on developing microgravity-enabled treatments for rare pulmonary diseases, marking a significant milestone in the intersection of commercial spaceflight and biotechnology.
According to the official press release, this initiative represents the first-ever commercial research collaboration focused on space-based drug formulation aimed at producing tangible therapies for patients on Earth. By utilizing Varda’s automated reentry capsules, the companies aim to process small-molecule medicines in space and return them to Earth for clinical evaluation and eventual patient use.
This collaboration signals a major shift from traditional, government-funded research conducted on the International Space Station (ISS) to a dedicated commercial supply chain model. By leveraging the unique physics of zero gravity, the partnership strives to revolutionize how life-saving therapies are formulated and delivered.
The Science of Microgravity Manufacturing
The core advantage of orbital pharmaceutical manufacturing lies in the absence of Earth’s gravitational pull. On Earth, gravity induces sedimentation and convection currents that can disrupt how molecules assemble during the manufacturing process. In the weightless environment of space, these disruptive forces vanish.
According to the provided research report, this microgravity environment allows molecules to assemble more slowly and uniformly. The result is the creation of highly ordered crystal structures, known as polymorphs, that are either significantly purer or entirely impossible to synthesize in a terrestrial laboratory.
Targeted Pharmaceutical Benefits
By exploiting microgravity’s influence on molecular structure and crystallization, Varda and United Therapeutics hope to achieve several critical breakthroughs in drug formulation. The targeted benefits of this orbital processing include:
- Improved Bioavailability: Allowing medications to dissolve and be absorbed more consistently by the human body.
- Enhanced Stability: Extending the shelf life of medications and potentially reducing the need for expensive, complex cold-chain storage.
- Advanced Delivery Methods: Enabling the creation of new inhaled or controlled-release therapies.
- Targeted Efficiency: Formulating drugs that deliver active ingredients more efficiently to the intended site of action.
Commercializing Orbital Infrastructure
Varda Space Industries, an El Segundo, California-based startup founded in 2021 and backed by Founders Fund, is pioneering the infrastructure required for this endeavor. Unlike traditional microgravity research on the ISS, which is frequently bottlenecked by crew schedules, contamination risks, and long wait times for return flights, Varda utilizes automated, free-flying “W-series” reentry capsules.
These capsules are designed to launch as secondary payloads, often aboard SpaceX missions. Once in orbit, they autonomously process materials before returning the finished products to Earth, landing at designated recovery sites such as the Australian desert.
Industry Perspectives
Leadership from both companies emphasized the transformative potential of moving pharmaceutical development into orbit. In the official announcement, Varda Space Industries CEO Will Bruey highlighted the unique advantages of their platform:
“Microgravity gives us a fundamentally different environment to manufacture pharmaceuticals that are otherwise impossible on Earth. Our collaboration with United Therapeutics strives to pioneer a new era in clinical development by completing the bridge from microgravity science to patient benefit on Earth.”
Martine Rothblatt, Ph.D., Chairperson and CEO of United Therapeutics, noted in the release that the collaboration will allow the biotechnology firm to explore how space-based manufacturing could contribute to significant improvements for rare pulmonary disease treatments.
Michael Reilly, Chief Strategy Officer of Varda Space Industries, underscored the commercial novelty of the venture, pointing out the historical limitations of space research:
“We’ve been learning from space for years, but I can’t name anything manufactured in space, brought down to Earth, and sold. So that is a first, or it will be a first.”
Financial Context and Next Steps
United Therapeutics Corporation (Nasdaq: UTHR) is a biotechnology giant with a market capitalization of $24.69 billion, specializing in innovative therapies for life-threatening conditions like pulmonary arterial hypertension. Following the announcement of the collaboration, industry reports noted that United Therapeutics’ stock was trading near its 52-week high of $609.35, reflecting strong investor confidence in the company’s innovative pipeline.
While the specific compounds and exact financial terms of the deal remain undisclosed, the agreement stipulates that United Therapeutics is compensating Varda to help identify new crystal forms of its existing drugs.
The timeline for this orbital manufacturing initiative is advancing rapidly. According to the research report, a launch carrying United Therapeutics’ drug samples aboard a Varda capsule could occur as early as early 2027. Once the capsules return to Earth, scientists at United Therapeutics will rigorously test the newly formed polymorphs to evaluate their enhanced properties.
AirPro News analysis
We observe that this partnership answers a long-standing question in the aerospace sector: whether orbital drug manufacturing can successfully transition from a scientific curiosity to a viable, scalable business model. For over two decades, microgravity research has been largely confined to the ISS, yielding promising scientific results that rarely translated into commercial manufacturing pipelines due to logistical and financial constraints.
As launch costs continue to decrease and automated satellite technology matures, space-based manufacturing is rapidly emerging as a practical tool for terrestrial industries. If Varda and United Therapeutics are successful in returning commercially viable, enhanced pharmaceuticals from orbit, it could pave the way for a new era of space-enabled medicine, fundamentally altering the economic landscape of both the commercial space sector and the global biotechnology industry.
Frequently Asked Questions (FAQ)
What is the goal of the Varda and United Therapeutics collaboration?
The partnership aims to develop improved formulations of treatments for rare pulmonary diseases by manufacturing small-molecule medicines in the microgravity environment of low Earth orbit.
How does microgravity improve drug manufacturing?
In space, the absence of gravity eliminates sedimentation and convection currents. This allows molecules to assemble more slowly and uniformly, creating highly ordered crystal structures (polymorphs) that can improve a drug’s bioavailability, stability, and delivery methods.
When will the first manufacturing mission launch?
A launch carrying United Therapeutics’ drug samples aboard a Varda reentry capsule is projected to happen as early as early 2027.
How do the drugs return to Earth?
Varda utilizes automated “W-series” reentry capsules that process the materials in orbit and then reenter the Earth’s atmosphere, landing at designated recovery sites such as the Australian desert.
Sources
Photo Credit: Varda Space Industries
Space & Satellites
NASA’s X-59 Advances Testing for Quiet Supersonic Flight
NASA’s X-59 aircraft undergoes detailed low-speed testing to validate performance before supersonic flights aimed at reducing sonic booms.
This article is based on an official press release from NASA.
NASA’s X-59 quiet supersonic research aircraft is advancing through a rigorous “envelope expansion” phase, but the agency’s latest updates reveal that the path to breaking the sound barrier is not strictly linear. According to an official May 14, 2026, mission update from NASA, engineers and test pilots are currently prioritizing the aircraft’s performance at lower speeds and altitudes to fully map the vehicle’s aerodynamic responses across its entire operating range.
The X-59 is the centerpiece of NASA’s Quesst (Quiet SuperSonic Technology) mission, an ambitious program designed to demonstrate that an aircraft can travel faster than the speed of sound without generating a disruptive sonic boom. Built by Lockheed Martin Skunk Works, the experimental jet features a highly specialized design, including a 38-foot-long nose and a top-mounted engine, engineered to reduce the traditional window-rattling boom to a gentle “sonic thump.”
While the ultimate target for the X-59 is to cruise at Mach 1.42 (approximately 937 mph) at an altitude of 55,000 feet, NASA’s current testing regimen underscores a meticulous, safety-first approach. By thoroughly validating the aircraft’s handling during subsonic cruising, takeoff, and landing, the Quesst team is ensuring the experimental jet is fully reliable before it begins acoustic validation flights over populated areas.
Expanding the Flight Envelope
The spring of 2026 has been a period of rapid progression for the X-59 program. Following its historic first flight on October 28, 2025, piloted by NASA test pilot Nils Larson, the aircraft has steadily achieved critical milestones. According to NASA’s mission data, the X-59 successfully completed its first wheels-up flight on April 3, 2026, allowing engineers to evaluate the aircraft’s aerodynamics in its fully streamlined configuration.
Accelerating the Testing Tempo
To gather critical flight data more efficiently, NASA has recently increased the tempo of its operations out of the Armstrong Flight Research Center in Edwards, California. On April 30, 2026, the agency executed its first “dual-flight day,” successfully completing the aircraft’s 11th and 12th flights within a single day over the Mojave Desert.
During these late-April tests, NASA reports that the X-59 flew at altitudes ranging from 12,000 to 43,000 feet. The aircraft pushed right up against the sound barrier, reaching speeds between Mach 0.8 and Mach 0.95, which translates to approximately 528 to 627 mph.
The Science of Slower Speeds
Despite the public anticipation surrounding the X-59’s supersonic capabilities, NASA’s May 14 update emphasizes the critical importance of subsonic testing. Understanding how the unique airframe handles at slower speeds is vital for the safety of the test pilots and the long-term success of the mission.
“Although NASA’s X-59 is designed to fly supersonic, its test flight schedule is about more than just going gradually faster and higher…”
Aerodynamic Validation
Because the X-59 utilizes an unconventional design to mitigate shockwaves, its low-speed handling characteristics must be carefully documented. The current testing phase ensures that the aircraft remains predictable and stable during the most vulnerable phases of flight, such as approach and landing. Only after these subsonic parameters are fully validated will NASA clear the aircraft to push beyond Mach 1 and achieve its target cruising altitude of 55,000 feet.
The Quesst Mission and Regulatory Goals
The data collected during these envelope expansion flights serves a much larger purpose than simply proving the X-59’s airworthiness. Since 1973, the United States has enforced a strict ban on overland civilian supersonic flight due to the noise pollution caused by sonic booms. This regulation severely limited the economic viability of previous supersonic transports like the Concorde, which was restricted to flying at supersonic speeds only over the ocean.
Once the X-59’s performance is fully validated, NASA plans to fly the aircraft over select U.S. communities to survey public response to the mitigated “sonic thump.” This acoustic data will then be shared with U.S. and international aviation regulators, including the Federal Aviation Administration (FAA) and the International Civil Aviation Organization (ICAO).
AirPro News analysis
At AirPro News, we view the successful acceleration of the X-59’s flight testing as a highly encouraging indicator for the broader aerospace sector. If NASA’s Quesst mission succeeds in providing regulators with the data needed to establish new, noise-based thresholds rather than blanket speed bans, it could trigger a seismic regulatory shift. Lifting the 1973 overland ban would effectively open the door for a new generation of commercial supersonic passenger jets and high-speed cargo planes. This would not only drastically reduce travel times across the continental United States but also revitalize a commercial supersonic industry that has been dormant since the Concorde’s retirement in 2003. The meticulous subsonic testing currently underway is the necessary foundation for this potential aviation revolution.
Frequently Asked Questions (FAQ)
What is the top speed of the NASA X-59?
According to NASA, the target cruising speed for the X-59 is Mach 1.42, which is approximately 937 mph, at an altitude of 55,000 feet.
When did the X-59 make its first flight?
The X-59 completed its historic first flight on October 28, 2025, piloted by NASA test pilot Nils Larson.
Why is commercial supersonic flight currently banned over land?
The U.S. government banned overland civilian supersonic flight in 1973 due to the disruptive and potentially damaging nature of sonic booms. NASA’s Quesst mission aims to replace the loud boom with a quiet “sonic thump” to encourage regulators to lift this ban.
Sources:
NASA
Photo Credit: NASA
Space & Satellites
SpaceX CRS-34 Mission Launches Critical Cargo to ISS in 2026
SpaceX’s CRS-34 mission launched 6,500 pounds of scientific and crew supplies to the ISS, supporting Expedition 74 and advancing AI and biomedical research.
This article is based on an official press release from NASA and supplementary mission data.
SpaceX successfully launched its 34th Commercial Resupply Services (CRS-34) mission for NASA on Friday, May 15, 2026. Lifting off from Cape Canaveral, the uncrewed Cargo Dragon spacecraft is currently en route to the International Space Station (ISS) carrying critical scientific payloads, crew supplies, and hardware.
According to the official NASA release authored by Mark A. Garcia, the mission is a vital component of the agency’s ongoing efforts to sustain orbital operations and support the Expedition 74 crew.
“At 6:05 p.m. EDT, nearly 6,500 pounds of scientific investigations and cargo launched to the International Space Station…”
, Mark A. Garcia, NASA
We note that this mission highlights a growing trend in aerospace research: dual-benefit science. The payloads aboard CRS-34 are designed not only to facilitate deep-space exploration but also to address pressing terrestrial challenges, including the energy demands of AI and the treatment of bone density loss.
Mission and Launch Details
A Reusable Fleet in Action
The launch took place at Space Launch Complex 40 (SLC-40) at Cape Canaveral Space Force Station in Florida. SpaceX utilized a flight-proven Falcon 9 rocket, specifically Booster B1096, which was making its sixth flight. The Cargo Dragon spacecraft, designated C209, is also embarking on its sixth journey to orbit, underscoring the routine reusability that now defines commercial spaceflight operations.
In total, the spacecraft is transporting 2,948 kilograms (6,499 pounds) of cargo. Mission manifests indicate this includes 831 kilograms (1,832 pounds) dedicated to scientific investigations and 618 kilograms (1,362 pounds) of crew supplies, alongside essential vehicle hardware and spacewalk equipment.
Arrival and Expedition 74
Upon its arrival on Sunday, May 17, 2026, at approximately 7:00 a.m. EDT, the Dragon is scheduled to autonomously dock at the forward port of the ISS Harmony module. NASA astronaut Jack Hathaway and European Space Agency (ESA) astronaut Sophie Adenot are tasked with monitoring the automated rendezvous.
They are part of the broader Expedition 74 crew, commanded by Roscosmos cosmonaut Sergey Kud-Sverchkov. The crew also includes NASA’s Jessica Meir and Chris Williams, as well as Roscosmos cosmonauts Sergey Mikaev and Andrey Fedyaev, who will immediately begin unpacking time-sensitive research samples upon the spacecraft’s arrival.
Key Scientific Payloads
Advancing AI and Space Weather Monitoring
A significant portion of the CRS-34 payload is dedicated to advanced technology and environmental monitoring. The STORIE (Storm Time O+ Ring current Imaging Evolution) instrument, a joint initiative between NASA and the U.S. Space Force, will study Earth’s “ring current.” This research aims to determine whether the charged particles responsible for severe space weather originate from the Sun or are pulled upward from Earth’s own upper atmosphere. Understanding this phenomenon is vital for protecting satellite infrastructure and terrestrial power grids from solar storms.
Additionally, the mission carries an experiment led by Dr. Volker Sorger at the University of Florida testing photonic AI chips. These semiconductor chips utilize light rather than electricity to perform complex artificial intelligence computations. By testing these components in the harsh radiation and thermal environment of space, researchers hope to pave the way for highly efficient, naturally chilled orbital data centers, potentially alleviating the massive energy consumption of AI infrastructure on Earth.
Biomedical Breakthroughs in Microgravity
Biomedical research remains a cornerstone of ISS operations. The “Green Bone” and MABL-B (Microgravity Associated Bone Loss-B) studies will investigate bone degradation, which occurs up to 12 times faster in microgravity than on Earth. The experiments will observe bone cell growth on a unique wooden scaffold and test methods to block the IL-6 protein pathway, a suspected driver of rapid bone loss. These findings could inform treatments for osteoporosis, a condition affecting millions globally.
Other biological studies include ODYSSEY, which examines bacterial behavior in microgravity to validate Earth-based space simulators, and SPARK, an investigation into how red blood cells and the spleen adapt to spaceflight.
AirPro News analysis
The CRS-34 mission exemplifies the maturing relationship between NASA and commercial partners like SpaceX. By relying on the Commercial Resupply Services program, NASA maintains a steady, cost-effective pipeline to low Earth orbit, freeing up resources for the Artemis program and deep-space exploration.
Furthermore, the specific selection of payloads for this mission reflects a strategic pivot toward “dual-benefit” science. While preparing humans for long-duration missions to Mars is the primary objective, the immediate terrestrial applications, such as mitigating the AI energy crisis and advancing osteoporosis treatments, demonstrate the tangible return on investment for space-based research. As the current solar cycle reaches its 11-year peak, instruments like STORIE also highlight the critical role of orbital outposts in safeguarding modern Earth-bound infrastructure.
Frequently Asked Questions
When did the SpaceX CRS-34 mission launch?
The mission launched on Friday, May 15, 2026, at 6:05 p.m. EDT from Cape Canaveral Space Force Station.
What is the Cargo Dragon carrying?
The spacecraft is carrying nearly 6,500 pounds (2,948 kg) of cargo, which includes 1,832 pounds of scientific investigations and 1,362 pounds of crew supplies.
When will the spacecraft dock with the ISS?
The Cargo Dragon is scheduled to autonomously dock with the ISS Harmony module on Sunday, May 17, 2026, at approximately 7:00 a.m. EDT.
Sources
Photo Credit: SpaceX
-
Training & Certification6 days agoCAE Explores Strategic Alternatives for Flightscape Aviation Software
-
Route Development4 days agoUS Advances $22B Overhaul of Washington Dulles Airport by 2034
-
MRO & Manufacturing6 days agoBoeing Commits $1B to Wichita Facilities and Workforce Expansion
-
Regulations & Safety7 days agoUnited Airlines Passenger Assaults Crew and Attempts Cockpit Breach
-
Space & Satellites2 days agoSpaceX CRS-34 Mission Launches Critical Cargo to ISS in 2026